Published in J Urol on August 01, 1989
Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history. Rev Urol (2008) 1.58
Defining and treating the spectrum of intermediate risk nonmuscle invasive bladder cancer. J Urol (2014) 1.14
Urothelial carcinoma of the bladder: definition, treatment and future efforts. Nat Rev Urol (2011) 1.11
Proposal for changes in cystoscopic follow up of patients with bladder cancer and adjuvant intravesical chemotherapy. BMJ (1994) 1.09
Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence. Br J Cancer (1996) 1.03
Epidermal growth factor receptor and bladder cancer. Postgrad Med J (2002) 1.02
Improving the management of superficial bladder cancer. BMJ (1993) 0.96
Update on the management of non-muscle invasive bladder cancer. Can Urol Assoc J (2010) 0.95
The clinical epidemiology of superficial bladder cancer. Dutch South-East Cooperative Urological Group. Br J Cancer (1993) 0.92
Urinary concentrations of the soluble adhesion molecule E-cadherin and total protein in patients with bladder cancer. Br J Cancer (1999) 0.87
Nomograms for prediction of disease recurrence in patients with primary Ta, T1 transitional cell carcinoma of the bladder. J Korean Med Sci (2008) 0.87
Non-muscle invasive bladder cancer risk stratification. Indian J Urol (2015) 0.83
Bladder cancer. Postgrad Med J (1996) 0.79
Immunohistochemical evaluation of cell cycle regulators: impact on predicting prognosis in stage t1 urinary bladder cancer. ISRN Urol (2012) 0.79
ACP Broadsheet 130: November 1991. Gross examination of bladder specimens. J Clin Pathol (1991) 0.79
Bladder carcinoma data with clinical risk factors and molecular markers: a cluster analysis. Biomed Res Int (2015) 0.77
Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: A prospective study. Indian J Urol (2014) 0.77
The value of extensive transurethral resection in the diagnosis and treatment of nonmuscle invasive bladder cancer with respect to recurrence at the first follow-up cystoscopy. Onco Targets Ther (2016) 0.77
Can efficiency of follow-up for superficial bladder cancer be increased? Ann R Coll Surg Engl (1993) 0.75
Prognostic utility of human complement factor H related protein test (the BTA stat Test). Br J Cancer (2001) 0.75
Cystoscopy in bladder cancer. BMJ (1994) 0.75
Pretreatment levels of serum osteoprotegerin and p53 protein and urine telomerase as prognostic factors affecting survival in Egyptian bladder cancer patients. Oncol Lett (2015) 0.75
Superficial bladder cancer. BMJ (1994) 0.75
Superficial bladder cancer: state of the art. Cancer Chemother Pharmacol (1994) 0.75
Use of nomograms as predictive tools in bladder cancer. World J Urol (2006) 0.75
Prospective randomized study of prophylaxis of superficial bladder cancer with epirubicin: the role of a central pathology laboratory. Nara Uro-oncology Research Group. (NUORG). Cancer Chemother Pharmacol (1994) 0.75
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol (2001) 11.17
Breast cancer clusters in the northeast United States: a geographic analysis. Am J Epidemiol (1997) 5.73
Tables of the number of patients required in clinical trials using the logrank test. Stat Med (1983) 5.34
Allocation of patients to treatment groups in a controlled clinical study. Br J Cancer (1978) 5.25
On the use of Pocock and Simon's method for balancing treatment numbers over prognostic factors in the controlled clinical trial. Biometrics (1976) 3.82
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res (1978) 3.51
Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance. J Natl Cancer Inst (1996) 2.98
Alfuzosin once daily facilitates return to voiding in patients in acute urinary retention. J Urol (2004) 2.49
Implications of a new dietary measurement error model for estimation of relative risk: application to four calibration studies. Am J Epidemiol (1999) 2.40
Empirical evidence of correlated biases in dietary assessment instruments and its implications. Am J Epidemiol (2001) 2.33
Injuries sustained on "bouncy castles". BMJ (1992) 2.20
Is a male infertility clinic of any use? Br J Urol (1986) 2.16
Alfuzosin 10 mg once daily in the management of acute urinary retention: results of a double-blind placebo-controlled study. Urology (2005) 2.01
Histological grade and other prognostic factors in relation to survival of patients with breast cancer. Br J Cancer (1979) 1.92
Laparoscopic ureterolithotomy: the Edinburgh experience. BJU Int (1999) 1.92
The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. Stat Med (1994) 1.90
Potential impact of genetic testing on cancer prevention trials, using breast cancer as an example. J Natl Cancer Inst (1995) 1.84
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. Stat Med (1986) 1.82
EAU guidelines on male infertility. Eur Urol (2005) 1.82
Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone. Lancet (1987) 1.79
Radio-immunoassay detection of interferon-gamma in urine after intravesical Evans BCG therapy. J Urol (1990) 1.66
The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol (1996) 1.63
Interpreting precursor studies: what polyp trials tell us about large-bowel cancer. J Natl Cancer Inst (1994) 1.61
Can energy adjustment separate the effects of energy from those of specific macronutrients? Am J Epidemiol (1994) 1.56
A prospective study of endoluminal ultrasound versus computerized tomography angiography for detecting crossing vessels at the ureteropelvic junction. J Urol (1999) 1.53
Retroperitoneal laparoscopy. BJU Int (1999) 1.49
Relationship among outcome, stage of disease, and histologic grade for 22,616 cases of breast cancer. The basis for a prognostic index. Cancer (1991) 1.49
The use of a Kolmogorov--Smirnov type statistic in testing hypotheses about seasonal variation. J Epidemiol Community Health (1979) 1.49
Laparoscopy in urology: indications and training. BJU Int (2002) 1.48
On the nature and extent of XY pairing at meiotic prophase in man. Cytogenet Cell Genet (1984) 1.46
Bayesian monitoring of phase II trials in cancer chemoprevention. J Clin Epidemiol (1999) 1.41
A stratified Wilcoxon-type test for trend. Stat Med (1990) 1.40
The future of prognostic factors in outcome prediction for patients with cancer. Cancer (1992) 1.39
Effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: interim report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party). Br Med J (Clin Res Ed) (1988) 1.39
J-wire facilitates retrograde manipulation of ureteric calculi prior to extracorporeal shock wave lithotripsy. Br J Urol (1992) 1.39
Matched pair analysis of ureteroscopy vs. shock wave lithotripsy for the treatment of upper ureteric calculi. Int J Clin Pract (2007) 1.39
Treatment of obstruction of urinary outflow. BMJ (1989) 1.38
Intravesical Evans strain BCG therapy: quantitative immunohistochemical analysis of the immune response within the bladder wall. J Urol (1992) 1.38
Stopping rules for clinical trials incorporating clinical opinion. Biometrics (1984) 1.33
Comparison of prednisolone and placebo in subfertile men with antibodies to spermatozoa. Lancet (1990) 1.31
Effect of starvation on the tissue composition of the small intestine in the rat. Am J Physiol (1968) 1.31
Mutations at the mitochondrial DNA polymerase (POLG) locus associated with male infertility. Nat Genet (2001) 1.31
Characterisation of the coding sequence and fine mapping of the human DFFRY gene and comparative expression analysis and mapping to the Sxrb interval of the mouse Y chromosome of the Dffry gene. Hum Mol Genet (1998) 1.30
Variations in the level of reporting by hospitals to a regional cancer registry. Br J Cancer (1978) 1.29
Randomised comparative studies in the treatment of cancer in the United Kingdom: room for improvement? Lancet (1979) 1.29
Expression of RBM in the nuclei of human germ cells is dependent on a critical region of the Y chromosome long arm. Proc Natl Acad Sci U S A (1997) 1.29
Comparison of 2 generations of piezoelectric lithotriptors using matched pair analysis. J Urol (2004) 1.28
Randomized, placebo-controlled, double-blind study of low-dose oral interferon-alpha in HIV-1 antibody positive patients. J Acquir Immune Defic Syndr (1992) 1.27
An assay for dopamine-beta-hydroxylase activity in tissues and serum. Experientia (1971) 1.26
Microdeletions in interval 6 of the Y chromosome of males with idiopathic sterility point to disruption of AZF, a human spermatogenesis gene. Hum Genet (1992) 1.19
Towards the molecular localisation of the AZF locus: mapping of microdeletions in azoospermic men within 14 subintervals of interval 6 of the human Y chromosome. Hum Mol Genet (1992) 1.19
Multivariate analysis of prognostic factors for operable rectal cancer. Lancet (1984) 1.18
The polyp prevention trial I: rationale, design, recruitment, and baseline participant characteristics. Cancer Epidemiol Biomarkers Prev (1996) 1.15
Monitoring clinical trials: conditional or predictive power? Control Clin Trials (1986) 1.14
Sustained-release alfuzosin and trial without catheter after acute urinary retention: a prospective, placebo-controlled. BJU Int (1999) 1.14
Sperm abnormalities and cigarette smoking. Lancet (1981) 1.14
Interplay between design and analysis for behavioral intervention trials with community as the unit of randomization. Am J Epidemiol (1995) 1.13
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology. J Med Genet (2003) 1.13
A review of our first 100 cases of laparoscopic nephrectomy: defining risk factors for complications. Br J Urol (1998) 1.12
Effect of different types and amounts of fat on the development of mammary tumors in rodents: a review. Cancer Res (1997) 1.11
Polymerase chain reaction screening for Y chromosome microdeletions: a first step towards the diagnosis of genetically-determined spermatogenic failure in men. Mol Hum Reprod (1996) 1.11
An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma. Br J Cancer (1987) 1.10
System delay in breast cancer in whites and blacks. Am J Epidemiol (1995) 1.09
Validation of intermediate end points in cancer research. J Natl Cancer Inst (1990) 1.07
Vasectomy by section, luminal fulguration and fascial interposition: results from 6248 cases. Br J Urol (1996) 1.07
Applying Bayesian ideas in drug development and clinical trials. Stat Med (1993) 1.07
The long-term outcome after laparoscopic nephroureterectomy: a comparison with open nephroureterectomy. BJU Int (2000) 1.07
Endourological management of severely encrusted ureteral stents. J Endourol (1999) 1.07
Serum dopamine-beta-hydroxylase activity in neuroblastoma. N Engl J Med (1972) 1.05
Single-center experience using three shockwave lithotripters with different generator designs in management of urinary calculi. J Endourol (2006) 1.05
Improving the quality of data in randomized clinical trials: the COMPACT computer package. COMPACT Steering Committee. Stat Med (1988) 1.03
Carcinoma in situ of the testis. Br Med J (Clin Res Ed) (1986) 1.03
A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma. Clin Oncol (1978) 1.02
Nesbit procedure for disabling Peyronie's curvature: a median follow-up of 84 months. Urology (2003) 1.02
Checking for completeness of 24-h urine collection using para-amino benzoic acid not necessary in the Observing Protein and Energy Nutrition study. Eur J Clin Nutr (2013) 0.99
Energy adjustment methods for nutritional epidemiology: the effect of categorization. Am J Epidemiol (1994) 0.99
Interpretation of energy adjustment models for nutritional epidemiology. Am J Epidemiol (1993) 0.99
Laparoscopic nephroureterectomy: making management of upper-tract transitional-cell carcinoma entirely minimally invasive. J Endourol (1998) 0.98
Changes in human serum dopamine- -hydroxylase activity with age. Nature (1972) 0.98
Sample size calculation for clinical trials: the impact of clinician beliefs. Br J Cancer (2000) 0.98
Bayesian design and analysis of two x two factorial clinical trials. Biometrics (1997) 0.98
Limitations of mortality data as a guide to comparative lung cancer incidence within an urban area. Public Health (1979) 0.97
Ureteroscopy. An alternative view. Br J Urol (1985) 0.97
Conditional logistic regression with sandwich estimators: application to a meta-analysis. Biometrics (1998) 0.97
Lymphocyte sub-populations in the male genital tract. Br J Urol (1985) 0.97
Factors affecting mortality following myeloablative cord blood transplantation in adults: a pooled analysis of three international registries. Bone Marrow Transplant (2010) 0.97
Pericentric inversion in human chromosome 1 and the risk for male sterility. J Med Genet (1987) 0.96
Measurement error and dietary intake. Adv Exp Med Biol (1998) 0.96
TNM (1978) in bladder cancer: use and abuse. Br J Urol (1980) 0.96
Postvoid residual urine in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: pooled analysis of eleven controlled studies with alfuzosin. Urology (2001) 0.95
Clearance of lower-pole stones following shock wave lithotripsy: effect of the infundibulopelvic angle. Eur Urol (1999) 0.94
Hand-assisted laparoscopic nephroureterectomy. BJU Int (1999) 0.94
48-hour cephradine and post-prostatectomy bacteriuria. Br J Urol (1980) 0.93
Cryptorchidism in Scotland. Br Med J (Clin Res Ed) (1987) 0.93
Analysis of the relationship between defective sperm function and the generation of reactive oxygen species in cases of oligozoospermia. J Androl (1989) 0.93
A unified method for monitoring and analysing controlled trials. Stat Med (1994) 0.93
Is conventional sperm analysis of any use? Br J Urol (1983) 0.93